History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Yankees Universe Fund Fred's Team Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook
Press Releases Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online
Making an Appointment
Dr. Douglas Levine and Dr. Nadeem Abu-Rustum
Dr. Douglas Levine and Dr. Nadeem Abu-Rustum, Director, Minimally Invasive Surgery (from left)

About 1,300 women with some form of gynecologic cancer come to Memorial Sloan-Kettering Cancer Center each year, including about 200 new patients with cervical cancer.

The primary forms of treatment for cervical cancer are surgery and/or combined radiation therapy and chemotherapy. Our team approach to treatment gives each patient the benefit of expertise that is unequaled in depth of experience and skill in treating every aspect of cervical cancer.

Minimally Invasive Surgery

For women diagnosed with early-stage cervical cancer, our surgeons have been leaders in the adoption of less invasive techniques such as laparoscopic surgery. In this procedure, a thin, lighted tube with a video camera at its tip (called a laparoscope) is inserted through a tiny incision in the abdominal wall, and the image is projected onto a large viewing screen. Guided by this highly magnified image, the surgeon can operate through tiny surgical "ports" using specially designed surgical instruments. Using a minimally invasive surgical approach results in fewer complications, shorter hospital stays, and lower costs compared to traditional, open abdominal surgery.

Use of Robotics for Surgery

Memorial Sloan-Kettering was the first cancer hospital to acquire a state-of-the-art robotic da Vinciā„¢ Surgical System for minimally invasive cancer surgery. This technology offers the surgeon a number of significant advantages, among them an enhanced view of the operating field and a greater range of motion. Our gynecologic surgeons use the robot to perform minimally invasive procedures for women with cervical cancer.

A Patient's Story
A Patient's Story
Read about Caroline's fight with early-stage cervical cancer

Radical Trachelectomy

The surgical removal of the uterus (a procedure known as hysterectomy) has been the traditional method used to treat cervical cancer. Memorial Sloan-Kettering is one of the only hospitals on the East Coast performing a type of surgery that has the potential to preserve a woman's ability to bear children even after she has been diagnosed with early invasive cervical cancer.

Called radical trachelectomy, which also means surgical removal of the cervix, this approach offers an alternative to hysterectomy. This procedure is performed on patients whose tumor is confined to the cervix, so doctors are able to leave a small portion of the cervix in place and spare the womb (the upper part of the uterus known as the fundus). Not until the surgery is underway can the surgeon decide if a radical trachelectomy is a treatment option, depending upon how deeply into the cervical tissue the cancer has spread.

Find a Clinical Trial
Find a Clinical Trial
Find out about new research studies for cervical cancer

Multimodal Therapies

For women diagnosed with cancer that has spread beyond the cervix, combination treatment with chemotherapy and radiation therapy has proven to be very effective. Our clinician-researchers continue to search for newer treatments to extend the benefits of this regimen to a greater number of our patients.

We have vast clinical experience in combination chemotherapy and radiation therapy (known as combined modality therapy), including a type of internal radiation known as high-dose brachytherapy, in which radioactive material is placed directly into or near a tumor.

For women with advanced cervical cancer, chemotherapy is the treatment of choice. We continue to be actively involved in new drug development and clinical trials aimed at improving the treatment options for these patients. In addition, we rely on a multidisciplinary approach to determine the best way to care for women with advanced disease in order to improve or maintain quality of life.

Last Updated: Aug. 24, 2007
PrintEmail This Page